Indications
Constipation, including with encopresis, preparation for endoscopic (rectoscopy) and X-ray examination of the gastrointestinal tract.
$31.00
Active ingredient: | |
---|---|
Dosage form: | |
Indications for use: | Constipation, Preparation for ultrasound and abdominal x-rays |
Constipation, including with encopresis, preparation for endoscopic (rectoscopy) and X-ray examination of the gastrointestinal tract.
Adults and children over 3 years old
Enter the entire contents of one microclyster rectally, inserting the tip to the full length (the length of the universal tip is 60.6 mm. )
Newborns and children under 3 years of age
Enter the entire contents of one microclyster rectally, inserting a universal tip half the length (see the mark on the tip).
If complaints persist for a long time, then you should consult a doctor.
For children under 3 years of age, it is also possible to use microclysters with a shortened tip (the length of the shortened tip is 47.3 mm). In this case, it is necessary to enter the entire contents of one microclyster rectally, inserting the tip to the full length. Â
Instructions for use:
Increased individual sensitivity to the components of the drug.
One ml of the solution contains:
Active ingredients:
sodium citrate-90 mg,
sodium lauryl sulfoacetate 70% – 12.9 mg (corresponds to 9 mg of sodium lauryl sulfoacetate),
sorbitol solution 70% – 893 mg (corresponds to 625 mg of sorbitol);
Auxiliary substances:
sorbic acid – 1 mg,
glycerol-125 mg,
purified water up to 1 ml.
Microclyster Microlax® can begin to fight constipation in 5-15 minutes.
One ml of the solution contains: Active ingredients: sodium citrate – 90 mg, sodium lauryl sulfoacetate 70% – 12.9 mg (corresponds to 9 mg of sodium lauryl sulfoacetate), sorbitol solution 70% – 893 mg (corresponds to 625 mg of sorbitol);Â Auxiliary substances: sorbic acid – 1 mg, glycerol-125 mg, purified water up to 1 ml
MICROLAX® is a combined drug that has a laxative effect. The effect occurs in 5-15 minutes. The composition of the drug includes sodium citrate (a peptizer that displaces bound water contained in the feces), sodium lauryl sulfoacetate (dilutes the contents of the intestine) and sorbitol (increases the laxative effect by stimulating the flow of water into the intestines). Increasing the amount of water through peptization and dilution helps soften the stool and facilitates bowel movement.
Constipation, including with encopresis, preparation for endoscopic (rectoscopy) and X-ray examination of the gastrointestinal tract.
Adequate and strictly controlled studies involving pregnant women have not been conducted. Since this drug is likely to be absorbed into the systemic circulation to a small extent, when used in accordance with the recommendations during pregnancy or lactation, it is not expected to develop undesirable effects for the fetus or infant.
Increased individual sensitivity to the components of the drug.
According to spontaneous reports of adverse events, adverse reactions that occur during the use of the drug, which were detected during the post-marketing period, were classified as follows: very frequent (≥10%), frequent (≥1%, but <10%), infrequent (≥0.1%, but <1%), rare (≥0.01%, but <0.1%), very rare (Disorders of the gastrointestinal tract. Very rare: abdominal pain (including abdominal discomfort, abdominal pain, and upper abdominal pain); anorectal discomfort, loose stools. Immune system disorders. Very rare: hypersensitivity reactions (e. g. urticaria).
There is a risk of developing colon necrosis with simultaneous oral / rectal use of sodium polystyrene sulfonate and sorbitol, which is part of the drug.
Adults and children over 3 years of age should enter the entire contents of one microclyster rectally by inserting the full-length tip (the length of the universal tip is 60.6 mm. )Newborns and children under 3 years of age should enter the entire contents of one microclyster rectally, inserting a universal tip half the length (see the mark on the tip). If complaints persist for a long time, then you should consult a doctor. For children under 3 years of age, it is also possible to use microclysters with a shortened tip (the length of the shortened tip is 47.3 mm). In this case, it is necessary to enter the entire contents of one microclyster rectally, inserting the tip to the full length. Instructions for use:
If symptoms persist, avoid prolonged use and consult your doctor. If the medicine has become unusable or the expiration date has expired-do not pour it into the waste water and do not throw it on the street! Place the medicine in a plastic bag and put it in the trash can. These measures will help protect the environment!
Solution for rectal use
Keep out of reach of children at a temperature not exceeding 25°C.
Microlax
solution for topical application
Nursing mothers as prescribed by a doctor, For adults, Pregnant women as prescribed by a doctor, For children from birth
Preparation for ultrasound and X-ray of the abdominal cavity, Constipation
Reviews
There are no reviews yet